Plain-English translation of NCT07643610 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
BEAT-SHOCK is a registry—a carefully organized collection of medical information—that follows patients who develop a serious heart condition called cardiogenic shock, where the heart suddenly can't pump blood effectively. Researchers at the University Hospital Basel in Switzerland are collecting detailed information about these patients' care, treatments, and outcomes to better understand which approaches help patients recover best.
Cardiogenic shock is a life-threatening emergency, and doctors need better information about what treatments work and how different patients respond. By gathering real-world data from hundreds of patients, researchers hope to improve how hospitals treat this condition in the future.
You likely qualify if…
You likely don't qualify if…
Participating means allowing the research team to collect and review your medical information during and after your hospital stay—things like test results, imaging scans, medications you received, and how you responded to treatment. You will not need to take any experimental medication or undergo extra procedures; the team simply gathers information from your routine care. Your medical information will be stored securely and used to help doctors understand cardiogenic shock better.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Enrollment target
~8,000 participants
Started
October 2025
Primary completion
October 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jasper Boeddinghaus, PD Dr. med.
University Hospital, Basel, Switzerland
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.